The NKTR Antibody (PACO04446) is a highly specific and sensitive tool for researchers studying NKTR, a novel target in cancer immunotherapy. This monoclonal antibody, produced in a mouse model, has been validated for use in various applications, including immunohistochemistry and flow cytometry. By targeting the NKTR protein, researchers can gain valuable insights into its role in immune response modulation and potential therapeutic applications in cancer treatment.NKTR, also known as a key regulator of immune responses, has been shown to play a critical role in tumor immunity and immune evasion mechanisms.
By targeting NKTR with this antibody, researchers can further investigate its impact on cancer progression and potentially develop targeted therapies for various cancer types. This antibody is an essential tool for researchers looking to advance our understanding of NKTR and its potential as a therapeutic target in oncology research.
Antibody Name:
NKTR Antibody
Antibody SKU:
PACO04446
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA, IHC, IF
Recommended Dilutions:
IHC:1:100-1:300, IF:1:200-1:1000
Species Reactivity:
Human
Immunogen:
synthesized peptide derived from the Internal region of human NK-TR.
Form:
Liquid
Storage Buffer:
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Purification Method:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Clonality:
Polyclonal
Isotype:
IgG
Conjugate:
Non-conjugated
Synonyms:
NKTR; NK-tumor recognition protein; NK-TR protein; Natural-killer cells cyclophilin-related protein
UniProt Protein Function:
Component of a putative tumor-recognition complex. Involved in the function of NK cells.
UniProt Protein Details:
NCBI Summary:
This gene encodes a membrane-anchored protein with a hydrophobic amino terminal domain and a cyclophilin-like PPIase domain. It is present on the surface of natural killer cells and facilitates their binding to targets. Its expression is regulated by IL2 activation of the cells. [provided by RefSeq, Jul 2008]
